Healthy Clinical Trial
Official title:
A Randomised, Double-blind, Parallel Groups, Placebo-controlled 6 Week Human Intervention Study Investigating the Effect of a Phospholipid Drink on Cognitive Performance in 6-8 Year Old School Children
NCT number | NCT03705572 |
Other study ID # | Arla02 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | May 2014 |
Est. completion date | April 2015 |
Verified date | October 2018 |
Source | University of Leeds |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Six week RCT intervention on the effects of phospholipid containing milk drink vs. placebo milk drink on cognitive performance in 6-8 year old school children.
Status | Completed |
Enrollment | 165 |
Est. completion date | April 2015 |
Est. primary completion date | April 2015 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 6 Years to 8 Years |
Eligibility |
Inclusion Criteria: - Male or female, aged 6-8 years. - Willingness to consume milk drinks during the study determined by a score of >5 on a taste testing Likert scale for at least one flavour of the milk drinks. - Ability to follow verbal and simple written instructions in English. - Normal vision, with appropriate corrective lenses if required. - Ability to understand cognitive testing instructions and responding requirements. Exclusion Criteria: - Poor general health. - Colour blindness. - Behavioural difficulties or attention disorders (e.g. Attention Deficit Hyperactivity Disorder). - Learning disabilities that interfere with the ability to understand written or verbal communications. - Inability to understand the objective of the cognitive tests, or carry out the tests. - Any food allergies or intolerances (e.g. lactose intolerance). - Acute illness, or feelings of unwell, within the week prior to testing. - Current administration of any psychotropic medication or supplementation in the month prior to testing, or during testing. - Hearing impairment that precludes the ability to follow verbal instructions. - Children already receiving milk at school unless parents are willing to substitute current milk with the study milk. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
University of Leeds | Arla Foods |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Rivermead Behavioural Memory Test for Children (RBMT-C) change from baseline | Test of immediate and delayed verbal memory recall. | Week 0, week 3 & week 6 | |
Secondary | Motor Screening Task (CANTAB suite) change from baseline | To identify motor impairment. Dependent variables: reaction time for each trial and distance from cross. | Week 0, week 3 & week 6 | |
Secondary | Spatial Recognition Memory (CANTAB suite) change from baseline | Dependent variables: number of correct trials and reaction time for each trial. | Week 0, week 3 & week 6 | |
Secondary | Spatial Span (CANTAB suite) change from baseline | Dependent variables: highest span reached, number of correct responses, number of incorrect responses and reaction time for each trial. | Week 0, week 3 & week 6 | |
Secondary | Reaction time (CANTAB suite) change from baseline | Dependent variables: mental reaction time and movement time for each trial, number of correct responses, number of incorrect responses and number of invalid responses. Two parts to the task included simple, one response option, and choice, 5 response options. | Week 0, week 3 & week 6 | |
Secondary | Subjective mood questionnaire change from baseline | Visual Analogue Scale. | Week 0, week 3 & week 6 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |